tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Can-Fite BioPharma Secures Brazilian Patent for A3AR-Based Sexual Dysfunction Therapy
PremiumCompany AnnouncementsCan-Fite BioPharma Secures Brazilian Patent for A3AR-Based Sexual Dysfunction Therapy
1M ago
Can-Fite BioPharma downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
Can-Fite BioPharma downgraded to Hold from Buy at D. Boral Capital
1M ago
Can-Fite BioPharma Sets 1-for-3,000 Reverse Share Split and ADS Ratio Change Effective Early January 2026
Premium
Company Announcements
Can-Fite BioPharma Sets 1-for-3,000 Reverse Share Split and ADS Ratio Change Effective Early January 2026
1M ago
Can-Fite BioPharma Adjusts Warrant Terms to Enhance Market Appeal
PremiumCompany AnnouncementsCan-Fite BioPharma Adjusts Warrant Terms to Enhance Market Appeal
2M ago
Can-Fite’s CF602 Secures Patent in Brazil for Erectile Dysfunction Treatment
Premium
Company Announcements
Can-Fite’s CF602 Secures Patent in Brazil for Erectile Dysfunction Treatment
3M ago
Can-Fite BioPharma receives Notice of Allowance from Brazil for patent on CF602
Premium
The Fly
Can-Fite BioPharma receives Notice of Allowance from Brazil for patent on CF602
3M ago
Can-Fite announces 9-year survival with complete cure with Namodenoson
PremiumThe FlyCan-Fite announces 9-year survival with complete cure with Namodenoson
3M ago
Can-Fite BioPharma Shareholders Approve Key Proposals
Premium
Company Announcements
Can-Fite BioPharma Shareholders Approve Key Proposals
3M ago
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
Premium
Ratings
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100